Panelists:
Nick Hutchinson
Head of Market Development
Just – Evotec Biologics
Priyanka Gupta
Senior Marketing Expert
Bioprocess Solutions
Sartorius
Miriam Monge
Head of Market Communication Strategy and Customer Advocacy
Sartorius
Michael Coolbaugh, PhD
Associate Director
Sanofi
- Time:
The demands of developing new biologic modalities like bispecific antibodies are pushing the limits of traditional drug manufacturing. For the modern biomanufacturer, process intensification is becoming the go-to method for maximizing productivity in both upstream and downstream processes. Globally, large biopharma companies have implemented intensified processes to produce 27 approved drugs used to treat cancer, cardiovascular disease, neurodegenerative diseases, and more. However, there is room for broader application of intensified strategies such as in downstream processing of biologics where 80 percent of protein manufacturing costs are incurred.
In this GEN webinar, experts from Sanofi, Evotec Biologics, and Sartorius will share insights and strategies from their experiences implementing intensified technologies throughout the manufacturing ecosystem, including outcomes in terms of process efficiency and product quality. They will share case studies that demonstrate how they use process intensification to improve individual processing operations as well as examples of facility-wide implementation. During the webinar, you’ll learn:
- Analysis of current and future trends that are shaping process intensification for biomanufacturing
- Cutting-edge continuous manufacturing solutions that boost productivity and lower costs
- Critical steps for adopting intensified processes to ensure safe and sustainable manufacturing
A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.
Produced with support from:
